Monoclonal antibodies made headlines in early October when President Donald Trump was treated for COVID-19 with an experimental monoclonal antibody drug made by Regeneron.
As part of a nationwide effort to discover more about the effects of this kind of therapy, … Read More »
News about a potential COVID-19 vaccine is announced almost daily, leading people to wonder when a vaccine will be available, and whether it will be safe. Edward Jones-Lopez, MD, MS, a Keck Medicine of USC infectious diseases expert and … Read More »
An estimated 5.5 million people in the United States live with Alzheimer’s disease, which is the most common form of dementia.
Keck Medicine of USC is enrolling individuals in an international Phase 3 clinical trial to examine … Read More »
When babies are born early — at or before 32 weeks — they are at risk for challenges, including developmental and learning disabilities. While they receive lots of care in a neonatal intensive care unit (NICU), there’s about … Read More »
Larissa Rodriguez, MD, professor of urology and obstetrics and gynecology at the Keck School of Medicine of USC, and Jason Kutch, PhD, associate professor at the USC Division of Biokinesiology and Physical Therapy, … Read More »
Keck Medicine of USC is enrolling volunteers as part of a multicenter clinical trial sponsored by AstraZeneca to determine if an experimental vaccine known as AZD1222 provides protection against the coronavirus. The trial will … Read More »
As the pandemic continues, physicians and researchers across the world are working doggedly to find ways to mitigate the toll of COVID-19, especially among populations experiencing infection surges. While many scientists are striving to create a vaccine, others … Read More »
Keck Medicine of USC physicians are launching a clinical trial to evaluate the efficacy and safety of baricitinib, an anti-inflammatory drug approved by the Food and Drug … Read More »
The Keck School of Medicine of USC has established a process to rapidly evaluate research related to COVID-19 and open opportunities for care to clinicians and patients, according to a memo distributed April 4.
The new … Read More »
Dry age-related macular degeneration (dry AMD) poses a significant clinical challenge. It is one of the leading causes of progressive blindness, robbing millions of people over the age of 65 of their central vision, and it often hinders … Read More »
Keck Medicine of USC urologists are launching a clinical trial to evaluate the effectiveness of spinal cord stimulation in patients with an overactive bladder due to neurological conditions — such as a spinal cord injury or … Read More »
The Keck School of Medicine of USC is launching a large clinical study to determine whether a man-made antibody would slow or stop the progression of Alzheimer’s disease by targeting memory-robbing plaques in the earliest stages of the illness.
Described as … Read More »
When Ray Goldsworthy, PhD, was just 13, he contracted spinal meningitis. Antibiotics saved his life but destroyed the cells in his inner ears responsible for processing sound.
“Within the span of one to two weeks, I went from hearing normally to … Read More »
The Alzheimer’s Therapeutic Research Institute (ATRI) of the Keck School of Medicine of USC is one of 25 premier research institutions that received a $4.7 million award to advance research on Down syndrome. The project, titled “Clinical Trials to Prevent … Read More »
A highly competitive $4.5 million grant from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) will support Keck School of Medicine of USC efforts to recruit patients from underrepresented populations into cardiac surgery clinical … Read More »
At first glance, the statistics for lung cancer may seem dire. But look closer and there’s more — much more — to the story. It’s true that lung cancer remains the leading cause of cancer death among men and women … Read More »
USC Norris Comprehensive Cancer Center has launched a study to determine how financial assistance for costs associated with clinical trial participation might increase enrollment, particularly among low-income patients and racial and ethnic minorities. The study, known as Improving Patient Access … Read More »
Lisa Cohen’s cancer battle led her to USC Norris physician-scientist, Dr. Preet M. Chaudhary, who is developing novel therapies that have the potential to dramatically improve the treatment of acute myeloid leukemia.
Young Americans with cancer have a far better prognosis than once thought due to a surprising new discovery about the role of HIV/AIDS, fundamentally altering a long-standing narrative about their cancer mortality, according to new findings by USC scientists.
For decades, … Read More »